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perspectives on CAM was the lack of scientific evidences. The attitudes on CAM were 
basically shaped based on their personal CAM use rather than knowledge gained 
during an academic course. Lack of knowledge on CAM was also attributing to the 
doctors’ reluctance in CAM discussion with their patients. Though addition of CAM 
courses into the medical curriculum was proposed by some of the doctors; the prac-
tical implication was criticized as some found medical curriculum heavily packed 
with the biomedical courses. ConClusions: Majority of the doctors in this study 
were skeptical and uncertain about CAM due to lack of scientific evidence. Doctor-
patient communication on CAM can only be improved when doctors’ knowledge 
on CAM can be improved by providing necessary training on CAM.
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objeCtives: Non-Hispanic Blacks and Hispanics are less likely than non-Hispanic 
Whites to be eligible for U.S. Medicare medication therapy management (MTM) 
services. The objectives for this study were to determine (1) racial/ethnic dispari-
ties in meeting MTM eligibility criteria as stipulated in the Patient Protection and 
Affordable Care Act (PPACA); and (2) whether there would be greater disparities in 
health/economic outcomes among MTM-ineligible than MTM-eligible groups (if 
so, the PPACA MTM eligibility criteria may aggravate existing disparities in these 
outcomes). Methods: Medicare Current Beneficiaries Survey (2007-2008) was ana-
lyzed. PPACA MTM eligibility was compared between Whites and minorities using 
logistic regression. Various other regression models were used for other study out-
comes (measures for health status, health services utilization/costs and medication 
utilization patterns). To determine difference in disparities across MTM eligibility 
categories, interaction terms were included between dummy variables for race/
ethnicity and MTM eligibility and were interpreted on the multiplicative term and 
using marginal effects. Results: The sample consisted of 12,966 Medicare benefi-
ciaries (weighted to 51,635,149). Blacks and Hispanics were less likely than Whites 
to meet PPACA MTM eligibility criteria (adjusted odds ratio [OR] = 0.66 [P< 0.05] for 
Blacks, and OR= 0.62 [P< 0.05] for Hispanics). Racial and ethnic disparities in self-
perceived health status (SPHS), activities of daily living (ADLs), and instrumental 
ADLs were greater among the MTM-ineligible than the MTM-eligible populations 
(e. g., for SPHS, difference in marginal effects between Whites and Blacks= 27.25 
[P< 0.01] across MTM eligibility categories, and between Whites and Hispanics= 20.62 
[P= 0.03] ). Disparities were smaller in number of chronic conditions and number and 
costs of physician visits among MTM-ineligible compared to MTM-eligible popula-
tions. No other variables exhibited significant interaction effects. ConClusions: 
The PPACA MTM eligibility criteria is not an ideal alternative in resolving disparity 
issues associated with Medicare MTM eligibility criteria. MTM eligibility criteria 
which reduce rather than aggravate disparities have yet to be identified/devised.
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objeCtives: To conduct a survey of the possible factors that cause the tension 
between patients and doctors. Methods: The survey including 16 items (8 for 
patients and 8 for doctors) was conducted in one of the Level A hospitals in south-
west region of China for a total of 853 questionnaires with 580 for patients and 273 
for doctors respectively. Microsoft Excel 2007 was used to perform data extraction and 
analysis. Results: The survey yielded to 822 questionnaires with a 96.37% response 
rate. Most of the patients (93.19%) want doctors to seek their opinions when providing 
the treatment. While 61.48% doctors indicated it was difficult to share decision-mak-
ing with patients. Account for 60.47% patients would like to obtain information from 
doctors. Whereas, 52.75% of doctors expressed that it was difficult to provide patient 
with high quality and reliable evidence or information. Twenty percent of the patients 
didn’t fully satisfied with the existing treatment, while 63% doctors indicated that it 
was difficult to meet patients’ desire. The reasons for the difficulty in communication 
were mainly about: short communication time (50.48%) and improper communica-
tion method (37.07%). Only 14.61% of doctors expressed that they had enough time to 
communicate with patients. ConClusions: Lack of ‘communication openness’ was 
identified as a major factor which hindered the shared decision-making, A successful 
bidirectional way to encourage shared decision-making to alleviate the current tense 
relationship for both sides is needed.
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intRoduCtion: (1) Since 2009 China had implemented national essential drug 
system, and issued first and second edition of NEDL (National Essential Drugs List) 
respectively in 2009 and 2013, which respectively covered 307 drugs and 520 drugs. 
(2) With development of Chinese health care reform, planning low-priced drug policy 
and adjusted essential drug system will impact on drug access. objeCtives: To 
describe Chinese policies’ development for promoting drug access, analyze the 
policies’ impact and potential lacks. Methods: Through collecting relevant poli-
cies from national departments and 31 provinces, apply descriptive statistics and 
comparison to summarize these policies’ impact. Results: (1) On May 2013 China 
involuntary job separation were significantly more likely to report zero expense on 
prescription drugs (odds ratio 1.37, 95% confidence interval (CI) 0.1. 11-1.71). Among 
those with non-zero drug expenses, job loss was associated with 12.8% increase in 
the out-of-pocket payment for the last prescription while controlling for personal 
characteristics and the prescription payment before the job loss. ConClusions: 
The findings from this study indicates that impacts of job loss may vary based on 
the health status of workers. Job loss may discourage workers from initiating drug 
treatment. For those already on medications, job loss is linked with an increase 
in drug expenses. It is unclear the increase is caused by the worse health status 
after job loss or the use of medications to replace other more costly medical care.
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objeCtives: Technological change in medicine has been a major cause of rising 
health care expenditures in many countries. The adoption of new drugs plays an 
important role in accounting for the growth of spending on prescription drugs. 
This paper uses the prescription drug market in Taiwan as an example to investi-
gate the evolution of prices and quantities of new drugs. Methods: A new drug 
is defined in our study as one that was included in the NHI formulary after 1996. 
The study sample includes new molecules, new formulations, combinations, and 
indications till 2006. We run a cross-sectional equation for the launch price of new 
NMEs, and a panel regression for price ratio of current price versus the launch prices. 
Furthermore, we run a panel regression model for both sales and market share of 
new drugs. Results: The preliminary results show that the degree of competition 
in a therapeutic market is weakly associated with the launch price, but negatively 
associated with the price ratio. The pioneer product can maintain a relatively higher 
price ratio in a longer period, but the price ratio of new drugs for chronic diseases 
decreases more than that for acute diseases. The competition of therapeutic mar-
ket increases the sales, but decreases the market share of new drugs. The pioneer 
product has a positive impact on the sales and market shares of new drugs. The 
sales of new drugs for chronic diseases are higher than that for acute diseases, but 
the growth of market share of new drugs for chronic diseases is lower than that for 
acute diseases. ConClusions: The competition in the therapeutic market does 
not affect the regulated prices at the time of entry, but decreases the price ratios 
over time. The characteristics of new drugs are the major factors affecting market 
expansion and market substitution of new drugs.
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objeCtives: As the majority of the Indian population still residing in India it is not 
only imperative to the pharmaceutical companies marketing medicines to foray in 
to the rural market. But there is very less understanding of the actual potential and 
preferences of the rural health care practitioners. Hence in this study an attempt is 
made to understand the prescriber potential and to also to know the preferences 
of health care practitioners towards the company representative visits. Methods: 
A questionnaire based survey was designed to study the prescriber potential in 211 
villages of Belgaum district of Karnataka State in India. The survey included semi 
structured questionnaire aimed at 191 physicians and 75 chemists. The data form 
the questionnaire was coded transferred to SPSS software to analyze. The data is 
summarized by descriptive statistics. Results: It was also found that most 44% of 
the doctors are in age group of 20 to 30 and only 11% doctors are well experienced. 
40% of the doctors consult average 35 patients daily. In Belgaum rural area 65% 
doctors preferred amoxicillin in case of bacterial infection and also 31% cefixime. 
The prescriber interviews also revealed the interest of prescribers towards updat-
ing their knowledge by Continuous Medical Education (CME) and also doctors are 
interested for tele-marketing calls to know the scientific information. Stockiest 
of Belgaum visits about 66% of the retail shops, hence product availability is not 
a problem. ConClusions: In India, there is a potential in rural market form the 
selected category like anti-infective, antipyretic, pain management and cough 
therapy products.
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objeCtives: The study aims to assess doctors’ perceptions towards Complementary 
and Alternative Medicines (CAM) in their medical practice, factors that affect the 
referral of CAM and suggestions to improve CAM in medical practice. Methods: 
A qualitative research approach was adopted to gain a better understanding of the 
current perceptions and practice held by doctors’ within their medical professions. 
In order to gain a wide perspective of the issue, eleven doctors were purposively 
selected who were working in academics, hospitals and in the community health 
clinics. Participants were interviewed using a semi-structured interview guide. A 
saturation point was reached after the 10th interview, and no new information 
emerged with the subsequent interviews. All interviews were transcribed verbatim 
and analyzed by means of a standard content analysis framework. Results: The 
doctors expressed a range of views on CAM that can be divided into two major 
themes: doctors’ knowledge and understanding towards CAM and doctors’ view-
point on CAM in their professional practice. A key factor which affected doctor’s 
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where the costs were allocated to the different cost-centres. Capital costs were 
annualised cost of capital item with life expectancy of more than 1 year and recur-
rent cost were all inputs consumed within a year. Total costs were then allocated 
to the in-patient and out-patient services based on historical financial data with a 
ratio of 1: 4. This was then followed by a stepwise approach of allocating the ancillary 
department cost centres to the clinical department cost centres. The unit cost per 
patient visit was calculated based on the number of visits for each department. Base 
year of 2010 was used to calculate the cost and patients visits. Costs were calculated 
from the perspective of the hospital. Results: The cost per visit to the out-patient 
department averaged at MYR 96.83 (USD 29.34). The cost per visit to the medical 
department and surgical department was MYR 138.66 (USD 42.02) and 273.39 (USD 
82.84) respectively. ConClusions: The findings provide an estimate of the costs 
for out-patient visit. At the current minimal fee of MYR 5.00 (USD 1.5), the Ministry 
of Health is subsidising more than 95.0% of the health care cost for each patient. 
These estimates provide the policy-makers with an understanding of the cost data 
should they need to establish a cost basis for payment rates.
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objeCtives: With the roll-out of public hospital reform in China, several provinces 
have started to implement the zero markup pilots in both municipal- and county-
levels. As the pioneer, Zhejiang is the first pilot province that has zero markup policy 
fully implemented in all levels. The aim of this study is to investigate the outcomes 
of Zhejiang zero markup policy and thus to predict effect of the policy on health 
expenditure. Methods: Official documents of public hospital reform and relevant 
reports were revised for the detail of how the loss of hospitals resulted from the 
removal of markup was subsidized. Statistical comparison on expenses variety and 
physician behavior between Zhejiang and other cases in China was used. Results: 
Documents released by Zhejiang Government indicated the removal of drug markup 
should be subsidized through increasing service charge and governmental financial 
support. After 6 months of implementation, it was reported that drug expenditure in 
sample hospitals had decreased by 7.78%, with the percentage of drug expenditure 
out of total out-patient and in-patient expense reducing by 6.67% and 8.7% respec-
tively. Overall diagnostic income increased by 425.31%, whereas incomes generated 
by care fee, surgery fee and treatment fee increased by 138.77%, 45.75% and 43.65% 
respectively. Patients visiting were also observed increased with a decrease in aver-
age amount per prescription. ConClusions: Switch of a significant proportion of 
health care expenditure from drug expenses to service charge indicated changes 
in the structure of hospital’s income, through which the value of health care labor 
market was manifested and the non-profit nature of public hospitals was restored. 
However, hospitals may have incentives to increase the number of services they pro-
vide to patients, especially when local governmental subsidy is not in place timely. 
It is predicted that such circumstance may frequently occur during rolling out the 
policy as local governments across the country differ in their financial capacity. As 
a result, the user charge of patient will still account for a significant proportion of 
total health care expenditure.
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bACkgRound: Financial burden due to health care costs are high in India and a 
small percentage of the population are protected through any health insurance 
program. To protect people from high economic cost of illness, and reduces inequal-
ity in health care access government of Kerala introduced a comprehensive health 
insurance scheme. objeCtives: This study tries 1. To explore the factors affect-
ing the enrollment in Comprehensive Health Insurance Scheme, 2. To find out the 
health care utilization pattern among insured and associated factors. Methods: 
Exploratory Case study, both quantitative and qualitative Methods used to track 
the objectives of the study. An interview conducted on 150 insured households. 
In-depth interviews conducted on 10 kudumbasree (women support groups) groups 
and 10 key informants’ interviews were also done. Results: In addition to educa-
tion and health risk, awareness about the scheme is high especially among females. 
About 97.4% of respondents were from poor families and, 40.7 % don’t have any 
permanent income. APL family (above poverty line) registration is negligible (2.6%) 
only. Around 91.3% don’t have any other form of health insurance coverage. 42% 
respondents utilized the scheme and 34.0% of households have had history of 
chronic diseases. Majority of respondents (97.3%) registered through kudumbasree 
group. All respondents reported that coverage is not enough and out patients care 
should be included. Qualitative interviews revealed that many eligible members 
were excluded, and delay in settling of claims, provider choice is limited. Women 
empowerment in health related matters and enrollment is appreciable through 
Kudumbasree groups. ConClusions: Access to health care and access to medicine 
is increased. Concerted effort is needed for the successful implementation and 
sustainability of the scheme.
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objeCtives: In this paper, we use the panel data of China Health and Nutrition 
Survey (CHNS) in 2000, 2004 and 2006 to study the impact of the income per 
NHFPC had released the second edition of NEDL, which increased to 520 drugs and 
allowed all provinces to implement after appropriate addition. Until the end of 
February 2014, nine provinces in China had supplemented average 251 drugs (aver-
age 121 western medicines and 130 TCM) on the basis of 520 drugs. The most was 535 
in Xinjiang and the least is 57 in Gansu. (2) Meanwhile, China NDRC was planning 
to introduce low-priced drug list covering 890 drugs, the price control of which will 
be released if average daily cost is less than 3 RMB for western drugs or 5 RMB for 
TCM. (3) On February 27, 2014 Guangdong province had released “low-priced drugs 
list of non-essential drugs” including 1103 drugs, then plus essential drugs in the 
province, relatively cheap drugs that patients could afford are theoretically up to 
1902. ConClusions: (1) These two policies had provided quantitatively safeguard 
for patients access to relatively cheap drugs close to 2,000. (2) Chinese “parallel 
development” policy for TCM and Western Medicine will be insisted on for a long 
term. (3) It needs more scientific mechanism designed to avoid the lacks of“double 
envelop”tendering and distortion of doctors’ income.
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objeCtives: Singapore ranks 6th in world’s health systems by WHO, yet spends 
proportionally less on health than any other high-income countries. We aimed to 
investigate how drugs are accessed and financed through the public health care 
system in Singapore Methods: Secondary research was conducted to identify and 
review relevant policy documents, published guidelines and reports on health care 
financing and drug access in the public health care setting. Relevant information 
was extracted and analysed independently by 2 reviewers with verification by a 
third reviewer. Results: The MOH maintains a Standard Drug List (SDL) which 
is divided into two parts, SDL 1 and SDL 2. Drugs included in SDL 1 follow closely 
WHO’s Essential Drug List while SDL 2 was introduced later to subsidise some 
expensive drugs. There are currently about 570 drug preparations listed in SDL. 
Subsidised patients pay S$1.40 per item for drugs in SDL 1 and 50% of the cost for 
drugs in SDL 2 by out-of-pocket or through their own or family members’ Medisave 
accounts. Non-subsidised patients pay the full cost of drugs in SDL. All patients pay 
the full cost for drugs not included in SDL. MediShield a state-run opt-out medi-
cal insurance scheme designed to cover medical expense including medications 
that Medisave alone would not be sufficient to cover. For those who cannot afford 
the subsidised charges, despite Medisave and MediShield coverage, Medifund is 
an endowment fund set up as a safety net to help needy Singaporeans. In 2010, 
Medication Assistance Fund (MAF) was launched to help eligible patients pay for 
selected expensive non-SDL drugs. MAF is means tested with up to 75% subsidy 
involving case-by-case evaluation for patients’ eligibility. ConClusions: The drug 
formulary and access schemes reflect the philosophy of shared responsibilities of 
public and individuals toward health in the public health care delivery in Singapore.
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objeCtives: To evaluate the economic impact of Specialist Outpatient Clinic (SOC) 
Pharmacy interventions Methods: A retrospective study in Singapore General 
Hospital (SGH) SOC Pharmacy on the interventions made with physicians, between 
Aug 2012 and Oct 2012. Each intervention was analysed and assigned with an 
Estimated Cost of Avoidance (ECA) level, consented to by 3 pharmacists with varying 
clinical experience from 2 years to 15 years. The ECA level ranges from 1 to 8, with 1 
having the least economic impact and 7 having the greatest economic impact. An 
ECA level of 8 has no economic impact as it signify non-acceptance of interventions 
by physicians. Subsequently, the economic impact per month is calculated by the 
total number of interventions in each ECA level, multiplied by the respective cost 
of avoidance, pre-determined for each ECA level based on national / institution 
standards, in Singapore Dollars. Results: The economic impact of SOC Pharmacy 
interventions is estimated to be ~SGD 900,000 over 3 months, with an average of ~ 
SGD 300,000 per month. With an average of 23000 prescriptions per month, it is esti-
mated that our SOC Pharmacy interventions saves ~ SGD 13 per prescription. Unlike 
traditional, direct methods to estimate the economic impact of pharmacy interven-
tions, our results highlighted a great portion of cost savings to both institutions and 
patients, which are often neglected. ConClusions: Interventions performed by 
Pharmacy staff have a great impact on cost savings to institution and also patients.
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objeCtives: Health care services in Malaysia are widely available and accessible 
at a minimal cost. However, in pursuing with the health care reform, policy-makers 
and hospital managers need to know the unit cost for the purpose of planning and 
efficiency of providing the services. This study estimated the cost of out-patient 
services in a public hospital. Methods: The study was conducted in a 341 bedded 
hospital that provide secondary level care to 24,486 in-patients and 127,389 spe-
cialist out-patients in 2010. The costs were estimated using a step-down approach 
